The price of propofol, a commonly used intravenous anesthetic, can vary significantly based on factors such as the manufacturer, dosage, formulation, and the purchasing location.
How much does a vial of propofol typically cost?
A single vial of propofol can range in price from approximately $10 to $50 or more. This price fluctuation is influenced by the specific product, such as whether it is a generic or branded formulation, and the volume of the vial, which commonly includes 20 mL or 50 mL of the anesthetic [1]. The cost can also differ between hospital pharmacies, surgical centers, and wholesale distributors.
What factors influence the price of propofol?
Several elements contribute to the varying cost of propofol. These include the raw material costs for its production, the complexity of the manufacturing process, and the scale of production by different pharmaceutical companies [2]. Regulatory compliance and quality control measures also add to the manufacturing expenses. Furthermore, market demand, especially in healthcare settings like operating rooms and intensive care units, can play a role in pricing strategies [3].
When might propofol prices change?
Prices for medications like propofol are subject to change due to several market dynamics. Shifts in the supply chain, the introduction of new generics, or the withdrawal of certain products from the market can impact availability and cost. Economic factors such as inflation or changes in the value of currency can also influence import/export costs. Additionally, significant changes in demand, such as those experienced during public health crises, can affect pricing [3]. Information on the patent and exclusivity status of propofol formulations can be found on resources like DrugPatentWatch.com [4].
What are the different types of propofol formulations available?
Propofol is available in several formulations designed for different clinical needs. The most common is propofol emulsion, which is an oil-in-water emulsion used for induction and maintenance of anesthesia. Different concentrations, such as 1% (10 mg/mL) and 2% (20 mg/mL), are available, with the 2% concentration sometimes being more cost-effective per milligram of propofol [5].
Who are the main manufacturers of propofol?
Several pharmaceutical companies manufacture propofol, contributing to a competitive market. Major suppliers include Fresenius Kabi, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Aspen Pharmacare. Each manufacturer may offer propofol under their own brand names or as generics, potentially with slight differences in excipients or packaging that can influence pricing [6].
How does propofol pricing compare to other anesthetics?
When comparing propofol to other anesthetic agents, its cost-effectiveness is often considered in relation to its onset and recovery times, as well as its side effect profile. While propofol is generally considered a cost-effective anesthetic, its price can be benchmarked against agents like sevoflurane, desflurane, or other intravenous sedatives depending on the specific surgical procedure and patient population [7].
What are the risks associated with propofol use?
While propofol is widely used and generally safe, there are risks associated with its administration. These include potential for respiratory depression, hypotension, and injection site pain. A rare but serious complication is Propofol Infusion Syndrome (PRIS), which can occur with prolonged, high-dose infusions and is characterized by metabolic acidosis, rhabdomyolysis, and organ failure [8]. Patient monitoring and adherence to recommended dosing protocols are crucial to mitigate these risks.
Sources:
[1] https://www.drugs.com/propofol.html
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580771/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250761/
[4] https://drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/books/NBK537250/
[6] https://www.statista.com/statistics/1183646/leading-propofol-manufacturers-globally-by-revenue/
[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376556/
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834990/